[Home]
[Full version]
Hip size of mothers linked to breast cancer in daughters
Oct 08 ,Medicine & Health
In a study of the maternity records of more than 6,000 women, David J.P. Barker, M.D., Ph.D., and Kent Thornburg, Ph.D., of Oregon Health & Science University discovered a strong correlation between the size and shape of a woman’s hips and her daughter’s risk of breast cancer. Wide, round hips, the researchers postulated, represent markers of high sex hormone concentrations in the mother, which increase her daughter’s vulnerability to breast cancer.
A woman’s hips are shaped at puberty when the growth of the hip bones is controlled by sex hormones but is also influenced by the level of nutrition. Every woman has a unique sex hormone profile which is established at puberty and persists through her reproductive life. The study’s findings show for the first time that the pubertal growth spurt of girls is strongly associated with the risk of breast cancer in their daughters.
The study, carried out with colleagues in Finland and the United Kingdom., is described in an article just published online by the peer-reviewed American Journal of Human Biology. The authors followed up on 6,370 women born in Helsinki from 1934 to 1944 whose mothers’ pelvic bones were measured during routine prenatal care. The study found that breast cancer rates were more than three times higher among the women in the cohort, born at or after term, whose mothers had wide hips. They were more than seven times higher if those mothers had already given birth to one or more children.
A woman’s vulnerability to breast cancer, the study found, was greater if her mother’s “intercristal diameter” – the widest distance between the wing-like structures at the top of the hip bone – was more than 30 centimeters, or 11.8 inches. The risk also was higher if these wing-like structures were round. The breast cancer risk was 2.5 times higher for the daughters of women in whom the widest distance was more than 3 centimeters greater than the distance at the front.
Barker, professor of medicine (cardiovascular medicine) in the OHSU School of Medicine as well as professor of clinical epidemiology at the University of Southampton in the U.K., is internationally known for discovering the relationship between low birth weight and the lifetime risk for coronary heart disease and other medical disorders, which the British Medical Journal has named the Barker Hypothesis. He has published more than 200 papers and written or edited five books about the developmental origins of chronic disease. He was honored in 2005 with the prestigious Danone International Prize for Nutrition for his pioneering research.
The OHSU study published today proposes that breast cancer is initiated in the first trimester of a pregnancy by exposure of the embryo’s developing breast tissue to the mother’s circulating sex hormones. The primary mammary cord, which gives rise to milk-producing breast lobules, develops in the fetus at 10 weeks. The fetal breast is known to be stimulated by circulating hormones; the intensity of the stimulation is such that half of all newborn babies have breast secretions.
“Our findings support the hypothesis that wide round hips reflect high levels of sex hormone production at puberty, which persist after puberty and adversely affect breast development of the daughters in early gestation,” the authors commented. They could only speculate, they said, on the exact nature of this adverse effect but pointed out: “Catechol estrogen, a metabolite or estradiol, is thought to cause chromosomal instability by breaking DNA strands. High catechol estrogen concentrations in the maternal circulation could produce genetic instability in differentiating breast epithelial cells, which would make the breast vulnerable to cancer in later life.”
“Epidemiological findings of this kind aren’t designed to define precise biological or molecular mechanisms,” said Grover Bagby, M.D., deputy director of the OHSU Cancer Institute. “However, for those of us involved in identifying the earliest molecular causes of cancer, these fascinating results define the types of questions we need to ask. This is a wake-up call telling us to pay attention to stem cell populations at the time of birth … a good deal earlier than we might have otherwise done. It is important to consider these cell populations because only by understanding the initial cause can we begin to develop rational strategies to prevent this very common cancer.”
The daughters who were the subjects of the study were all born during 1934-1944 at either Helsinki University Central Hospital or City Maternity Hospital, the two maternity hospitals in Finland’s capital. The occurrence of breast cancer among them was ascertained from national registers of all hospital admissions and deaths in Finland. Three hundred of them had had breast cancer of whom 48 died from the disease. Their mean age when they were diagnosed was 54.
The findings shed new light on the link between breast cancer and nutrition. “Mothers whose daughters developed breast cancer were of similar height to the other mothers,” Barker and Thornburg reported. “This suggests that they had similar nutrition through childhood. Our findings do not therefore indicate that good nutrition through childhood is linked to breast cancer in the next generation. But they do show that the pubertal growth spurt of girls, which reflects the level of nutrition, is strongly associated with the risk of breast cancer in their daughters.”
Source: Oregon Health & Science University
Related stories:
Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
Essential for life in higher animals, vitamin D, once linked to only bone diseases such as rickets and osteoporosis, is now recognized as a major player in contributing to overall human health, emphasizes UC Riverside's Anthony Norman, an international expert on vitamin D.
Feeding your body's defenses against cancer
David Servan-Schreiber was 31 when he was diagnosed with a walnut-size brain tumor and given 6 months to live. After surgery and chemotherapy, the young neuroscientist asked his oncologist if he should change his diet.
The dietary supplement genistein can undermine breast cancer treatment
Women taking aromatase inhibitors to treat breast cancer or prevent its recurrence should think twice before also taking a soy-based dietary supplement, researchers report.
Creating lung cancer risk models for specific populations refines prediction
Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA repair capacity, according to research teams led by epidemiologists at The University of Texas M. D. Anderson Cancer Center in two complementary papers appearing in the September issue of
Cancer Prevention Research.
Age at puberty linked to mother's prenatal diet
A high-fat diet during pregnancy and nursing may lead to the child having an early onset of puberty and subsequent adulthood obesity, according to a new animal study. The results were presented Monday, June 16, at The Endocrine Society's 90th Annual Meeting in San Francisco.
Get a Little Sun This Summer – It Could Help Save Your Life
As summer comes and people across America get ready to start slathering on the sunscreen, a note of caution is in order – a little sunshine is good for you.
Vitamin D in brain function
In a definitive critical review, scientists at Children’s Hospital & Research Center Oakland ask whether there is convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction. Joyce C. McCann, Ph.D., assistant staff scientist and Bruce N. Ames, Ph.D., senior scientist at Children’s Hospital Oakland Research Institute (CHORI) conclude that there is ample biological evidence to suggest an important role for vitamin D in brain development and function, and that supplementation for groups chronically low in vitamin D is warranted. Their conclusions will be published on April 22, 2008 in the Federation of American Societies for Experimental Biology (FASEB) Journal.
Study shows drug effective in treating, preventing breast cancer
A new study of an estrogen-derived drug shows promise as a treatment for breast cancer and breast cancer metastases to bone.
[Home]
[Full version]